Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 10, 2026
Sumant Kulkarni's Stock Ratings
Canaccord Genuity Analyst
Sumant Kulkarni is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
1.12%
Smart Score
Overall Average Return Percentile
38th
Number of Ratings
100
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/09/2026 | LBRX | Buy Now | LB Pharmaceuticals | $37.22 | 74.64% | → $65 | Initiates | → Buy | Get Alert | |
| 09/15/2026 | DFTX | Buy Now | Definium Therapeutics | $37.40 | 108.56% | $64 → $78 | Maintains | Buy | Get Alert | |
| 08/18/2026 | ANVS | Buy Now | Annovis Bio | $1.20 | 1316.67% | $17 → $17 | Maintains | Buy | Get Alert | |
| 08/13/2026 | DFTX | Buy Now | Definium Therapeutics | $37.40 | 71.12% | $58 → $64 | Maintains | Buy | Get Alert | |
| 08/10/2026 | CRVO | Buy Now | CervoMed | $3.27 | 450.46% | $27 → $18 | Maintains | Buy | Get Alert | |
| 08/04/2026 | STOK | Buy Now | Stoke Therapeutics | $24.00 | 141.67% | $60 → $58 | Maintains | Buy | Get Alert | |
| 08/03/2026 | NBIX | Buy Now | Neurocrine Biosciences | $142.44 | 47.43% | $200 → $210 | Maintains | Buy | Get Alert | |
| 07/30/2026 | BIIB | Buy Now | Biogen | $225.71 | 9.88% | $245 → $248 | Maintains | Buy | Get Alert | |
| 07/28/2026 | MPLT | Buy Now | MapLight Therapeutics | $8.83 | 171.8% | $43 → $24 | Maintains | Buy | Get Alert | |
| 07/27/2026 | ZVRA | Buy Now | Zevra Therapeutics | $11.39 | 75.59% | $29 → $20 | Maintains | Buy | Get Alert | |
| 07/24/2026 | MPLT | Buy Now | MapLight Therapeutics | $8.83 | 386.98% | $35 → $43 | Maintains | Buy | Get Alert | |
| 07/16/2026 | ATAI | Buy Now | AtaiBeckley | — | — | → $8 | Downgrade | Buy → Hold | Get Alert | |
| 07/07/2026 | ATAI | Buy Now | AtaiBeckley | — | — | $15 → $17 | Maintains | Buy | Get Alert | |
| 07/01/2026 | HELP | Buy Now | Helus Pharma | $11.95 | 251.46% | $45 → $42 | Maintains | Buy | Get Alert | |
| 06/30/2026 | DFTX | Buy Now | Definium Therapeutics | $37.40 | 55.08% | $60 → $58 | Maintains | Buy | Get Alert | |
| 06/29/2026 | ACAD | Buy Now | ACADIA Pharmaceuticals | $19.93 | 80.63% | $32 → $36 | Maintains | Buy | Get Alert | |
| 06/26/2026 | CMPS | Buy Now | Compass Pathways | $12.04 | 66.12% | $18 → $20 | Maintains | Buy | Get Alert | |
| 06/16/2026 | DFTX | Buy Now | Definium Therapeutics | $37.40 | 1.6% | $38 → $38 | Maintains | Buy | Get Alert | |
| 06/11/2026 | ZVRA | Buy Now | Zevra Therapeutics | $11.39 | 154.61% | $29 → $29 | Maintains | Buy | Get Alert | |
| 06/09/2026 | ZVRA | Buy Now | Zevra Therapeutics | $11.39 | 154.61% | $24 → $29 | Maintains | Buy | Get Alert | |
| 05/07/2026 | ACAD | Buy Now | ACADIA Pharmaceuticals | $19.93 | 60.56% | $33 → $32 | Maintains | Buy | Get Alert | |
| 04/20/2026 | ATAI | Buy Now | AtaiBeckley | — | — | $14 → $15 | Maintains | Buy | Get Alert | |
| 04/16/2026 | DFTX | Buy Now | Definium Therapeutics | $37.40 | 1.6% | $25 → $38 | Maintains | Buy | Get Alert | |
| 04/14/2026 | ANVS | Buy Now | Annovis Bio | $1.20 | 1316.67% | $17 → $17 | Maintains | Buy | Get Alert | |
| 04/07/2026 | NBIX | Buy Now | Neurocrine Biosciences | $142.44 | 40.41% | $164 → $200 | Maintains | Buy | Get Alert | |
| 04/01/2026 | BIIB | Buy Now | Biogen | $225.71 | 8.55% | $230 → $245 | Maintains | Buy | Get Alert | |
| 03/26/2026 | CMPS | Buy Now | Compass Pathways | $12.04 | 49.51% | $20 → $18 | Maintains | Buy | Get Alert | |
| 03/20/2026 | STOK | Buy Now | Stoke Therapeutics | $24.00 | 150% | $36 → $60 | Maintains | Buy | Get Alert | |
| 03/19/2026 | MPLT | Buy Now | MapLight Therapeutics | $8.83 | 296.38% | → $35 | Initiates | → Buy | Get Alert | |
| 03/13/2026 | CLNN | Buy Now | Clene | $3.83 | 1152.48% | $48 → $48 | Maintains | Buy | Get Alert | |
| 02/27/2026 | ACAD | Buy Now | ACADIA Pharmaceuticals | $19.93 | 65.58% | $31 → $33 | Maintains | Buy | Get Alert | |
| 02/18/2026 | CMPS | Buy Now | Compass Pathways | $12.04 | 66.12% | $15 → $20 | Maintains | Buy | Get Alert | |
| 02/09/2026 | BIIB | Buy Now | Biogen | $225.71 | 1.9% | $220 → $230 | Maintains | Buy | Get Alert | |
| 01/06/2026 | GHRS | Buy Now | GH Research | $21.11 | 84.75% | $35 → $39 | Maintains | Buy | Get Alert | |
| 01/05/2026 | STOK | Buy Now | Stoke Therapeutics | $24.00 | 50% | $28 → $36 | Maintains | Buy | Get Alert | |
| 11/20/2025 | CYBN | Buy Now | Cybin | — | — | $70 → $45 | Maintains | Buy | Get Alert | |
| 11/07/2025 | MNMD | Buy Now | Mind Medicine | — | — | $16 → $25 | Maintains | Buy | Get Alert | |
| 11/06/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $19.93 | 55.54% | $29 → $31 | Maintains | Buy | Get Alert | |
| 11/06/2025 | ZVRA | Buy Now | Zevra Therapeutics | $11.39 | 110.71% | $25 → $24 | Maintains | Buy | Get Alert | |
| 11/05/2025 | STOK | Buy Now | Stoke Therapeutics | $24.00 | 16.67% | $24 → $28 | Maintains | Buy | Get Alert | |
| 10/29/2025 | NBIX | Buy Now | Neurocrine Biosciences | $142.44 | 15.14% | $160 → $164 | Maintains | Buy | Get Alert | |
| 10/22/2025 | ATAI | Buy Now | ATAI Life Sciences | — | — | $11 → $14 | Maintains | Buy | Get Alert | |
| 09/30/2025 | ANVS | Buy Now | Annovis Bio | $1.20 | 1316.67% | $17 → $17 | Maintains | Buy | Get Alert | |
| 08/18/2025 | CLNN | Buy Now | Clene | $3.83 | 1152.48% | $83 → $48 | Maintains | Buy | Get Alert | |
| 08/07/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $19.93 | 45.51% | $27 → $29 | Maintains | Buy | Get Alert | |
| 08/01/2025 | CMPS | Buy Now | Compass Pathways | $12.04 | 24.59% | $15 → $15 | Maintains | Buy | Get Alert | |
| 07/29/2025 | CRVO | Buy Now | CervoMed | $3.27 | 725.69% | $21 → $27 | Maintains | Buy | Get Alert | |
| 07/28/2025 | ATAI | Buy Now | ATAI Life Sciences | — | — | $12 → $11 | Maintains | Buy | Get Alert | |
| 07/08/2025 | CYBN | Buy Now | Cybin | — | — | $73 → $70 | Maintains | Buy | Get Alert | |
| 07/02/2025 | ATAI | Buy Now | ATAI Life Sciences | — | — | $11 → $12 | Maintains | Buy | Get Alert | |
| 06/17/2025 | SAGE | Buy Now | Sage Therapeutics | — | — | $8 → $8.5 | Maintains | Hold | Get Alert | |
| 05/15/2025 | ANVS | Buy Now | Annovis Bio | $1.20 | 1316.67% | $26 → $17 | Maintains | Buy | Get Alert | |
| 05/06/2025 | NBIX | Buy Now | Neurocrine Biosciences | $142.44 | 12.33% | $158 → $160 | Maintains | Buy | Get Alert | |
| 05/02/2025 | BIIB | Buy Now | Biogen | $225.71 | -2.53% | $265 → $220 | Maintains | Buy | Get Alert | |
| 04/28/2025 | NBIX | Buy Now | Neurocrine Biosciences | $142.44 | 10.92% | $163 → $158 | Maintains | Buy | Get Alert | |
| 03/18/2025 | CRVO | Buy Now | CervoMed | $3.27 | 542.2% | $12 → $21 | Maintains | Buy | Get Alert | |
| 03/13/2025 | ZVRA | Buy Now | Zevra Therapeutics | $11.39 | 119.49% | $23 → $25 | Maintains | Buy | Get Alert | |
| 03/13/2025 | VYGR | Buy Now | Voyager Therapeutics | $2.49 | 381.93% | $14 → $12 | Maintains | Buy | Get Alert | |
| 02/28/2025 | CMPS | Buy Now | Compass Pathways | $12.04 | 24.59% | $23 → $15 | Maintains | Buy | Get Alert | |
| 02/13/2025 | BIIB | Buy Now | Biogen | $225.71 | 17.41% | $298 → $265 | Maintains | Buy | Get Alert | |
| 02/12/2025 | SAGE | Buy Now | Sage Therapeutics | — | — | $9 → $8 | Maintains | Hold | Get Alert | |
| 02/12/2025 | CYBN | Buy Now | Cybin | — | — | $86 → $73 | Maintains | Buy | Get Alert | |
| 02/07/2025 | NBIX | Buy Now | Neurocrine Biosciences | $142.44 | 14.43% | $172 → $163 | Maintains | Buy | Get Alert | |
| 01/31/2025 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $119 → $132 | Downgrade | Buy → Hold | Get Alert | |
| 01/06/2025 | BTAI | Buy Now | BioXcel Therapeutics | — | — | $7 → $5 | Maintains | Buy | Get Alert | |
| 12/11/2024 | CRVO | Buy Now | CervoMed | $3.27 | 266.97% | $65 → $12 | Maintains | Buy | Get Alert | |
| 11/19/2024 | CYBN | Buy Now | Cybin | — | — | $86 → $86 | Maintains | Buy | Get Alert | |
| 11/18/2024 | GHRS | Buy Now | GH Research | $21.11 | 32.64% | $31 → $28 | Maintains | Buy | Get Alert | |
| 11/18/2024 | ATAI | Buy Now | ATAI Life Sciences | — | — | $11 → $11 | Maintains | Buy | Get Alert | |
| 11/14/2024 | ZVRA | Buy Now | Zevra Therapeutics | $11.39 | 101.93% | $25 → $23 | Maintains | Buy | Get Alert | |
| 11/14/2024 | VYGR | Buy Now | Voyager Therapeutics | $2.49 | 462.25% | $14 → $14 | Maintains | Buy | Get Alert | |
| 11/14/2024 | CYBN | Buy Now | Cybin | — | — | $96 → $86 | Maintains | Buy | Get Alert | |
| 11/14/2024 | CLNN | Buy Now | Clene | $3.83 | 2065.74% | $86 → $83 | Maintains | Buy | Get Alert | |
| 10/04/2024 | CLNN | Buy Now | Clene | $3.83 | 2144.02% | $94 → $86 | Maintains | Buy | Get Alert | |
| 09/23/2024 | CYBN | Buy Now | Cybin | — | — | $114 → $96 | Maintains | Buy | Get Alert | |
| 09/18/2024 | ZVRA | Buy Now | Zevra Therapeutics | $11.39 | 93.15% | $24 → $22 | Maintains | Buy | Get Alert | |
| 09/16/2024 | MNMD | Buy Now | Mind Medicine | — | — | $16 → $14 | Maintains | Buy | Get Alert | |
| 08/30/2024 | BTAI | Buy Now | BioXcel Therapeutics | — | — | $7 → $7 | Maintains | Buy | Get Alert | |
| 08/06/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $17 → $9 | Maintains | Hold | Get Alert | |
| 08/06/2024 | CLNN | Buy Now | Clene | $3.83 | 2352.77% | $94 → $94 | Reiterates | Buy → Buy | Get Alert | |
| 08/02/2024 | CMPS | Buy Now | Compass Pathways | $12.04 | 298.7% | $50 → $48 | Maintains | Buy | Get Alert | |
| 07/25/2024 | CRVO | Buy Now | CervoMed | $3.27 | 1887.77% | $65 → $65 | Maintains | Buy | Get Alert | |
| 06/27/2024 | BTAI | Buy Now | BioXcel Therapeutics | — | — | $7 → $7 | Maintains | Buy | Get Alert | |
| 06/20/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $107 → $113 | Maintains | Buy | Get Alert | |
| 06/13/2024 | CARA | Buy Now | Cara Therapeutics | — | — | $10 → $1 | Downgrade | Buy → Hold | Get Alert | |
| 05/07/2024 | STOK | Buy Now | Stoke Therapeutics | $24.00 | -16.67% | $21 → $20 | Maintains | Buy | Get Alert | |
| 05/06/2024 | GHRS | Buy Now | GH Research | $21.11 | 46.85% | $30 → $31 | Maintains | Buy | Get Alert | |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $142.44 | 15.14% | $154 → $164 | Maintains | Buy | Get Alert | |
| 04/30/2024 | ANVS | Buy Now | Annovis Bio | $1.20 | 2066.67% | $36 → $26 | Maintains | Buy | Get Alert | |
| 04/26/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $21 → $17 | Maintains | Hold | Get Alert | |
| 04/23/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $100 → $107 | Maintains | Buy | Get Alert | |
| 04/08/2024 | CRVO | Buy Now | CervoMed | $3.27 | 1887.77% | $50 → $65 | Maintains | Buy | Get Alert | |
| 03/26/2024 | STOK | Buy Now | Stoke Therapeutics | $24.00 | -12.5% | $18 → $21 | Maintains | Buy | Get Alert | |
| 03/14/2024 | BTAI | Buy Now | BioXcel Therapeutics | — | — | $18 → $7 | Maintains | Buy | Get Alert | |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $19.93 | 65.58% | $40 → $33 | Maintains | Buy | Get Alert | |
| 03/06/2024 | CARA | Buy Now | Cara Therapeutics | — | — | $11 → $10 | Maintains | Buy | Get Alert | |
| 02/23/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $101 → $100 | Maintains | Buy | Get Alert | |
| 02/20/2024 | BIIB | Buy Now | Biogen | $225.71 | 35.13% | $310 → $305 | Maintains | Buy | Get Alert | |
| 02/15/2024 | CRVO | Buy Now | CervoMed | $3.27 | 1429.05% | → $50 | Initiates | → Buy | Get Alert | |
| 12/29/2023 | ANVS | Buy Now | Annovis Bio | $1.20 | 2900% | → $36 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved